Goldberg Y P, MacFarlane J, MacDonald M L, Thompson J, Dube M-P, Mattice M, Fraser R, Young C, Hossain S, Pape T, Payne B, Radomski C, Donaldson G, Ives E, Cox J, Younghusband H B, Green R, Duff A, Boltshauser E, Grinspan G A, Dimon J H, Sibley B G, Andria G, Toscano E, Kerdraon J, Bowsher D, Pimstone S N, Samuels M E, Sherrington R, Hayden M R
Xenon Pharmaceuticals Inc., 3650 Gilmore Way, Burnaby, BC V5G4W8, Canada.
Clin Genet. 2007 Apr;71(4):311-9. doi: 10.1111/j.1399-0004.2007.00790.x.
Congenital indifference to pain (CIP) is a rare condition in which patients have severely impaired pain perception, but are otherwise essentially normal. We identified and collected DNA from individuals from nine families of seven different nationalities in which the affected individuals meet the diagnostic criteria for CIP. Using homozygosity mapping and haplotype sharing methods, we narrowed the CIP locus to chromosome 2q24-q31, a region known to contain a cluster of voltage-gated sodium channel genes. From these prioritized candidate sodium channels, we identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7. The mutations completely co-segregated with the disease phenotype, and nine of these SCN9A mutations resulted in truncation and loss-of-function of the Nav1.7 channel. These genetic data further support the evidence that Nav1.7 plays an essential role in mediating pain in humans, and that SCN9A mutations identified in multiple different populations underlie CIP.
先天性无痛觉(CIP)是一种罕见病症,患者的痛觉感知严重受损,但在其他方面基本正常。我们从七个不同国籍的九个家庭中识别并收集了个体的DNA,这些家庭中的患病个体符合CIP的诊断标准。使用纯合性定位和单倍型共享方法,我们将CIP基因座定位到2q24 - q31染色体,该区域已知包含一组电压门控钠通道基因。从这些优先候选钠通道中,我们在编码钠通道蛋白Nav1.7的SCN9A基因中鉴定出10个突变。这些突变与疾病表型完全共分离,其中9个SCN9A突变导致Nav1.7通道截短并丧失功能。这些遗传数据进一步支持了Nav1.7在介导人类疼痛中起关键作用的证据,并且在多个不同人群中鉴定出的SCN9A突变是CIP的病因。